Introduction
============

There are several reports in the literature on survival and disease-free intervals and on their relationship to surgical-pathological factors in cervical carcinoma of the uterus [@R8287681-1] , [@R8287681-2] , [@R8287681-3] , [@R8287681-4] . Among these factors, pelvic lymph node involvement and tumor stage are well-established prognostic parameters. The histopathological grading of cervical cancer, however, is one of the more controversial factors, especially in squamous cell carcinomas (SCC) [@R8287681-2] ,  [@R8287681-5] ,  [@R8287681-6] . Historically, grading of cervical SCCs was performed using Broderʼs system or modifications thereof based on the degree of keratinization, cytological atypia and mitotic activity [@R8287681-7] ,  [@R8287681-8] . This grading system has been adopted by the WHO classification and is still valid, but it tends to be vague and unprecise [@R8287681-6] ,  [@R8287681-9] . Therefore, the present study was designed to evaluate the prognostic impact of the conventional grading based on the degree of keratinization within a large cohort of SCCs. A potential correlation of the conventional tumor grade with the recurrence-free and overall survival as well as pelvic lymph node metastases was used to determine the prognostic significance of grading in squamous cell cervical carcinomas. This may help to better define the role of tumor grade in cervical SCC and its possible consequences on clinical treatment decisions.

Material and Methods
====================

Patients
--------

Data from 467 consecutive squamous cell cervical cancer patients, clinically staged FIGO IB1 to IIB, who underwent upfront surgery were obtained from the files of the Institute of Pathology, University Hospital of Leipzig, Germany. Patients who received neoadjuvant therapy, those with incomplete local tumor resection and non-squamous cell histology were excluded from the study. Prior to the introduction of the TMMR-technique [@R8287681-10] at our institution, all women were treated by a radical abdominal hysterectomy Piver type III [@R8287681-11] . All patients with parametrial involvement and/or lymph node metastases underwent adjuvant intracavitary radiotherapy (ICRT) and external beam chemoradiation.

Pathological examination
------------------------

The pathological examination of the radical hysterectomy specimen was performed in a standardized manner [@R8287681-12] . All tumors were staged and classified according to the WHO and TNM-classifications [@R8287681-6] ,  [@R8287681-13] .

As a detailed description of the different grades is not included in the current WHO classification [@R8287681-6] , tumors were graded in accordance to previous studies [@R8287681-14] ,  [@R8287681-15] ,  [@R8287681-16] ,  [@R8287681-17] . In well-differentiated tumors (G1), the tumor cell nests were composed of keratinocyte-like cells with easily visible keratinization features (layered or cytoplasmic keratin). In the poorly differentiated tumors (G3), the squamous morphology was only noticeable in a small area of the tumor, not exceeding 1% of the whole tumor. The moderately differentiated tumors (G2) showed an intermediate degree of squamous differentiation between the well- and poorly differentiated ones ( [Fig. 1 a](#FI8287681-1){ref-type="fig"} to [c](#FI8287681-1){ref-type="fig"} ).

![ Histologic images of different grades of squamous cell carcinoma of the uterine cervix. **a**  G1: well-differentiated SCC: tumor cell nests with easily visible keratinization features (layered or cytoplasmic keratin). **b**  G2: moderately differentiated SCC with focal keratinization within the tumor cells. **c**  G3: tumor cell nests with squamous features without keratinization.](10-1055-a-0828-7681-igf01ac){#FI8287681-1}

The original H & E-stained slides were re-examined on low power magnification (× 25). If necessary, the infiltrating tumor cell nests were screened at intermediate power fields (× 100) for single cell keratinization and intercellular bridges. Two to six slides per case were investigated (mean 2.7 per case).

Follow-up data
--------------

Follow-up data were retrieved from the medical records. Written informed consent was obtained from all patients. Additionally, the study was approved by the Institutional Review Board.

Recurrence-free survival (RFS) was calculated from the day of diagnosis until tumor recurrence or end of follow-up. Overall survival (OS) was calculated from the day of diagnosis until death or end of follow-up. Kaplan-Meier survival curves and Log rank tests were used to analyze the survival data. Cox regression analyses were fitted to estimate the impact of grading. All statistical analyses were performed with IBM SPSS Statistics version 24.0.

Results
=======

Grading and prognosis
---------------------

A total of 467 cases were available for review. The patient characteristics are summarized in [Table 1](#TB8287681-1){ref-type="table"} .

###### 

**Table 1**  Patient characteristics (n = 467).

  ---------------------------------- ---------------
  Follow-up (months)                 
  Median (range)                     69 (2 -- 182)
  Age (years)                        
  Median (range)                     41 (23 -- 74)
  Mean ± SD                          42 ± 11
  Post-surgical stage distribution   
  pT1b1                              233 (49.9%)
  pT1b2                              55 (11.8%)
  pT2a                               49 (10.5%)
  pT2b                               130 (27.8%)
  Pelvic lymph node involvement      
  No (pN0)                           314 (67.2%)
  Yes (pN1)                          153 (32.8%)
  Tumor grade                        
  G1                                 215 (46.0%)
  G2                                 143 (30.6%)
  G3                                 109 (23.3%)
  Lymphovascular space involvement   
  None (L0)                          169 (36.2%)
  Yes (L1)                           298 (63.8%)
  Recurrent disease                  
  No                                 346 (74.1%)
  Yes                                121 (25.9%)
  ---------------------------------- ---------------

46.0% (n = 215) presented with well-differentiated tumors (G1), 30.6% (n = 143) showed moderate differentiation (G2) and 23.3% (n = 109) were poorly differentiated (G3).

The three grading groups were prognostically relevant for recurrence-free (p = 0.008; [Fig. 2 a](#FI8287681-2){ref-type="fig"} ) but not for overall survival (p = 0.089; [Fig. 2 b](#FI8287681-2){ref-type="fig"} ).

![ Kaplan-Meier curves for the prognostic impact of conventional tumor grading in squamous cell carcinoma of the uterine cervix using a 3-tiered grading system (please see text). **a**  Recurrence-free survival. **b**  Overall survival.](10-1055-a-0828-7681-igf02ab){#FI8287681-2}

A separate analysis of well- and moderately differentiated tumors regarding recurrence-free and overall survival was performed and revealed no significant difference (p = 0.002 for 5-year recurrence-free survival and p = 0.033 for 5-year overall survival, [Table 2](#TB8287681-2){ref-type="table"} ). This is illustrated in [Fig. 2 b](#FI8287681-2){ref-type="fig"} where the survival curves are merging. Therefore, the well- and moderately differentiated carcinomas were merged into a low-grade group, whereas the poorly differentiated carcinomas formed the high-grade group. 358/467 patients (76.6%) were found to have low-grade, 109/467 (23.3%) high-grade tumors.

###### 

**Table 2**  5-year-recurrence-free (RFS) and -overall survival (OS) of the different grading groups using the conventional grading system for squamous cell carcinomas of the uterine cervix (p-values \[Log rank test\]).

  ---- ------------------------------------- ----------------------- -----------------------
       **5-year recurrence-free survival**   **p-values**            
  G1   80.4% (95% CI: 74.7 -- 86.0%)         p = 0.089 (G1 vs. G2)   p = 0.002 (G1 vs. G3)
  G2   74.2% (95% CI: 66.9 -- 81.5%)                                 
  G3   64.4% (95% CI: 54.9 -- 73.8%)         p = 0.162 (G2 vs. G3)   
                                             global: p = 0.008       
       **5-year overall survival**           **p-values**            
  G1   76.4% (95% CI: 70.0 -- 82.8%)         p = 0.603 (G1 vs. G2)   p = 0.033 (G1 vs. G3)
  G2   76.4% (95% CI: 69.3 -- 83.5%)                                 
  G3   67.8% (95% CI: 58.6 -- 77.0%)         p = 0.121 (G2 vs. G3)   
                                             global: p = 0.089       
  ---- ------------------------------------- ----------------------- -----------------------

As illustrated in [Fig. 3](#FI8287681-3){ref-type="fig"} , there was a significant difference between low- and high-grade tumors regarding the recurrence-free and overall survival, respectively. The 5-year recurrence-free survival for G1/G2 versus G3 tumors was 77.9% (95% CI 73.4 -- 82.3%) versus 64.4% for the G3 tumors (95% CI 54.9 -- 73.8%; p = 0.008). G1/G2 tumors showed a 5-year overall survival of 76.9% (95% CI 72.3 -- 81.5%) versus 67.8% for the G3 tumors (95% CI 58.6 -- 77.0%; p = 0.031). The survival rates are shown in [Table 3](#TB8287681-3){ref-type="table"} .

![ Kaplan-Meier curves for the prognostic impact of conventional tumor grading in squamous cell carcinoma of the uterine cervix using a 2-tiered grading system (please see text). **a**  Recurrence-free survival. **b**  Overall survival.](10-1055-a-0828-7681-igf03ab){#FI8287681-3}

###### 

**Table 3**  5-year-recurrence-free (RFS) and -overall survival (OS) of the different grading groups using the conventional grading system for squamous cell carcinomas of the uterine cervix (p-values \[Log rank test\]).

  ------- ------------------------------------- --------------
          **5-year recurrence-free survival**   **p-values**
  G1/G2   77.9% (95% CI: 73.4 -- 82.3%)         p = 0.008
  G3      64.4% (95% CI: 54.9 -- 73.8%)         
          **5-year overall survival**           **p-values**
  G1/G2   76.9% (95% CI: 72.3 -- 81.5%)         p = 0.031
  G3      67.8% (95% CI: 58.6 -- 77.0%)         
  ------- ------------------------------------- --------------

Grading and lymph node involvement
----------------------------------

The frequency of pelvic lymph node involvement for the different grading systems used is presented in [Table 5](#TB8287681-5){ref-type="table"} .

###### 

**Table 5**  Pelvic lymph node involvement within different grading groups.

  Conventional grading                                           
  ---------------------- ----------- ----------- ------- ------- -------
  pN0                    67.4%       67.8%       66.1%   67.6%   66.1%
  pN1                    32.6%       32.2%       33.9%   32.4%   33.9%
  p-value                p = 0.953   p = 0.764                   

The conventional three-tiered grading system failed to predict pelvic lymph node involvement. The odds ratios for G1 versus G2 (0.98 \[95% CI: 0.62 -- 1.54\]) and G2 versus G3 (1.08 \[95% CI: 0.64 -- 1.84\]) were not statistically different. Also, the binary grading was unable to predict pelvic lymph node involvement (OR 1.07 \[95% CI: 0.68 -- 1.7\]; p = 0.76).

Discussion
==========

Clinical and postsurgical tumor stage as well as lymph node status are the most powerful predictors of outcome in cervical cancer [@R8287681-2] ,  [@R8287681-3] ,  [@R8287681-4] . The data regarding the prognostic impact of the tumor grade in squamous cell cancers (SCC) of the uterine cervix are controversial, and several approaches using different morphologic variables have been applied [@R8287681-15] .

Historically, cervical SCCs were graded using Broderʼs system [@R8287681-7] or modifications thereof based on the degree of keratinization [@R8287681-8] . This particular grading system of cervical SCCs is currently mentioned in the last two editions of the WHO classification [@R8287681-6] ,  [@R8287681-9] and is referred to as the conventional grading in order to separate it from other grading systems. In an earlier GOG-study, the three-year disease-free interval correlated significantly with the conventional tumor grade (G1: 90.6%, G2: 86.0% and for G3: 76.1%; p = 0.001) [@R8287681-14] . In a small study of 97 patients, grading had an impact on overall survival [@R8287681-18] . Other studies including those with multivariate approaches showed no prognostic significance of conventional grading [@R8287681-1] ,  [@R8287681-16] . In the present study, the conventional grading failed to show a prognostic impact on overall survival. There were no differences between well-differentiated (G1) and moderately differentiated (G2) tumors in regards to recurrence-free and overall survival ( [Fig. 2](#FI8287681-2){ref-type="fig"} and [Table 2](#TB8287681-2){ref-type="table"} ). After merging G1 and G2 tumors into low-grade tumors, the two-tiered conventional grading of cervical SCCs showed a prognostic impact both on recurrence-free and overall survival ( [Fig. 3](#FI8287681-3){ref-type="fig"} and [Tables 2](#TB8287681-2){ref-type="table"} and [3](#TB8287681-3){ref-type="table"} ).

In the present study, both the conventional three-tiered and the binary grading system failed to predict pelvic lymph node involvement ( [Table 5](#TB8287681-5){ref-type="table"} ).

In multivariate analyses including pelvic lymph node status, grading and the post-surgical tumor stage, the binary grading system was prognostically significant for recurrence-free as well as overall survival ( [Table 4](#TB8287681-4){ref-type="table"} ).

###### 

**Table 4**  Cox-regression analyses for recurrence-free and overall survival.

                                  HR                         p-values
  ------------------------------- -------------------------- ------------
  **Recurrence-free survival**                               
  Pelvic lymph node involvement                              
  No (pN0)                        ref                        
  Yes (pN1)                       2.7 (95% CI: 1.8 -- 3.9)   p \< 0.001
  Histological tumor grade                                   
  Low-grade (G1 + G2)             ref                        
  High-grade (G3)                 1.8 (95% CI: 1.2 -- 2.6)   p = 0.003
  Post-surgical stage                                        
  pT1b1                           ref                        
  pT1b2                           2.2 (95% CI: 1.2 -- 3.5)   p = 0.013
  pT2a                            1.4 (95% CI: 0.7 -- 2.8)   p = 0.373
  pT2b                            2.4 (95% CI: 1.5 -- 3.7)   p \< 0.001
  **Overall survival**                                       
  Pelvic lymph node involvement                              
  No (pN0)                        ref                        
  Yes (pN1)                       2.8 (95% CI: 1.9 -- 4.1)   p \< 0.001
  Histological tumor grade                                   
  Low-grade (G1 + G2)             ref                        
  High-grade (G3)                 1.7 (95% CI: 1.1 -- 2.4)   p = 0.011
  Post-surgical stage                                        
  pT1b1                           ref                        
  pT1b2                           1.6 (95% CI: 0.9 -- 3.0)   p = 0.107
  pT2a                            1.7 (95% CI: 0.9 -- 3.3)   p = 0.102
  pT2b                            2.7 (95% CI: 1.7 -- 4.1)   p \< 0.001

The advantage of the binary grading system may be the easier morphological categorization using only two rather than three different categories as well as the better reproducibility. While the conventional three-tiered grading system failed to predict prognosis, the binary system was useful in predicting both a reduced recurrence-free and overall survival. One limitation of the present study may be that it includes a variety of different stages of cervical carcinoma which may impact the results. The inclusion of different stages may also be responsible for the failure to predict pelvic lymph node involvement within the different grading groups.

Many attempts regarding the definition of grading systems on SCCs of the cervix uteri have been made [@R8287681-15] . Within that context, an invasive front grading was suggested [@R8287681-19] . This type of grading was first introduced in head and neck SCCs [@R8287681-20] and evaluates the degree of keratinization, nuclear pleomorphism, pattern of invasion and peritumoral host response at the infiltrative edge of SCCs. In cervical cancer, however, data on this grading system are very limited. Very recently, tumor cell budding (evaluating tumor growth by cell nest size) was studied in cervical SCC [@R8287681-21] . The tumor budding as a variant of the grading of a malignancy was previously validated in esophageal, lung and oral SCC.

Furthermore, studies that discuss tumor grade as a prognostic factor give no detailed description of the grading system that was applied [@R8287681-22] ,  [@R8287681-23] . At this point, there is no well-accepted and widely used grading system for cervical SCCs [@R8287681-24] ,  [@R8287681-25] , nor has one been recommended by the current WHO classification [@R8287681-6] . Because of these limitations, tumor grading is not listed as a required but rather a recommended feature in the most recent recommendations of the International Collaboration on Cancer Reporting [@R8287681-5] for cervical cancer. The German national guidelines for the diagnosis and treatment of cervical carcinoma point out that grading should not be used as a single factor for adjuvant treatment decision [@R8287681-26] .

Finally, additional studies are required to define standardized and reproducible criteria for grading with stage-by-stage analyses and a multivariate approach.

Conclusions
===========

A binary grading model for the conventional tumor grade (based on the degree of keratinization) in SCC of the uterine cervix may be suitable for the prognostic survival evaluation but failed to predict pelvic lymph node involvement.
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